Cargando…
Prognostic Value of VEGF in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Meta-Analysis
BACKGROUND: Hepatocellular carcinoma (HCC) is characterized by rich vascularization in the tumor, and vascular endothelial growth factor (VEGF) plays important roles in vascularization. The results of the roles of VEGF in predicting efficacy of sorafenib in HCC are conflicting. In this meta-analysis...
Autores principales: | Cao, Guangchao, Li, Xiaoyun, Qin, Chao, Li, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617189/ https://www.ncbi.nlm.nih.gov/pubmed/26476711 http://dx.doi.org/10.12659/MSM.894617 |
Ejemplares similares
-
Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis
por: Zhang, Yue, et al.
Publicado: (2017) -
Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysis
por: Shang, Jin, et al.
Publicado: (2017) -
Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017) -
Transcatheter hepatic arterial chemoembolization and sorafenib for hepatocellular carcinoma: a meta-analysis of randomized, double-blind controlled trials
por: Li, Jun, et al.
Publicado: (2017) -
Sorafenib in the treatment of patients with hepatocellular carcinoma (HCC) and microvascular infiltration: a systematic review and meta-analysis
por: Gu, Wang, et al.
Publicado: (2020)